Mixed vaccine trial launched in Hull
Researchers in Hull have launched a new clinical trial to understand what happens when people receive different vaccines to protect them against Covid-19.
The study, led by Hull University Teaching Hospitals NHS Trust, will take place over the next 10 months.
It will test whether there is any benefit to a person’s immunity when they receive different forms of the vaccine.
Researchers at Hull Royal and Castle Hill Hospital are aiming to recruit local people to the trial, particularly those from BAME communities, to take part in the mixed vaccine study.
Priyai Parkinson, Research Delivery Lead at Hull University Teaching Hospitals NHS Trust, said:
“We are looking for volunteers to take part in a study to see what happens in the immune system when a second (boost) dose of Covid-19 vaccine is a different type to the first.
“We are looking for people who have already had their first dose of Covid-19 vaccine through the NHS vaccine roll out programme.
“If you are aged 50 years and over, and have received only one dose of Covid-19 vaccine from the NHS vaccine programme so far, then you may be eligible to take part in the study.”
The trust played a major part in the trial of the Oxford Astra Zeneca vaccine last year, one in every 45 participants recruited by the Hull team.
Contact Gi Hull
Email us: news@gi-media.co.uk
Follows us on Facebook for all the latest local stories, breaking news and to join the conversation